Adverse immunological responses against non-viral nanoparticle (NP) delivery systems in the lung

Adverse immunological responses against non-viral nanoparticle (NP) delivery systems in the lung

There is a large, unmet medical need to treat chronic obstructive pulmonary disease, asthma, idiopathic pulmonary fibrosis and other respiratory diseases. New modalities are being developed, including gene therapy which treats the disease at the DNA/RNA level. Despite recent innovations in non-viral...

Full description

Bibliographic Details
Main Authors: Leonor de Braganca, G. John Ferguson, Jose Luis Santos, Jeremy P. Derrick
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:Journal of Immunotoxicology
Subjects:
nanoparticles
gene therapy
lung
inhalation
immune response
Online Access:http://dx.doi.org/10.1080/1547691X.2021.1902432

Internet

http://dx.doi.org/10.1080/1547691X.2021.1902432

Similar Items